These cancers are highly aggressive and metastatic, and upregulation of mesenchymal biomarkers is observed in metastases compared to primary tumors (Shen et al., 2011; Wiles et al., 2013), suggesting that these tumors metastasize via an MET‐independent route. The gene discussed is MET; the disease is cancer.